Skip to main content

Nordicus Partners Corp

corporate_fare Company Profile

Nordicus Partners Corp

NORD·OTC·Trade & Services·CIK 0001492966

Nordicus Partners Corporation operates as a publicly traded business accelerator and holding company for Nordic life sciences companies in the United States. The company focuses on developing medicines supporting oral health. It also provides corporate finance activities, which include business and market development, growth strategies, talent acquisition, partnership building, capital raising, and facilitating company acquisitions and sales. Nordicus Partners Corporation was formerly known as EKIMAS Corporation and changed its name in May 2023. The company was founded in 1993 and is based in Beverly Hills, California.

This symbol changed hands

NORD now belongs to Nordicus Partners Corp. Previously it belonged to Nord Anglia Education Inc.

Nordicus Partners Corp (OTC:NORD) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 4 items for NORD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-28, rated 8/10. Across its 4 most recent items scored 7 or higher, the top rating is 9/10, with 4 rated 8 or above. Recent SEC coverage for NORD spans 10-Q, 8-K, 10-K.

Recent high-impact activity:

  • Nordicus Partners Reports $2.3M Quarterly Loss, Cash Drops to $5,784, and Discloses $600K Convertible Note
  • Nordicus Partners Secures $500K Convertible Note with 250K Commitment Shares
  • Nordicus Partners 10-K Flags Going Concern, $4M Loss, and Control Weaknesses
  • Nordicus Partners Closes $554K Private Placement at $2.75 Per Share

Short Interest & Short Volume

1.07 days to cover

FINRA reported short interest of 1,721 shares in NORD as of the September 15, 2026 settlement, a 39.6% increase from the prior period — about 1.1 days to cover at its recent average daily volume. On October 2, 2026, 91.9% of NORD volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)1,721 shares as of September 15, 2026
Change vs prior period▲ 39.6%
Days to cover1.07 at avg daily volume of 1,607
Daily short volume (FINRA facilities)91.9% of 1,360 shares on October 2, 2026
3-day average short volume51.8%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Insider Transactions

NORD files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with N →
$4.01 +0.01% today
52-week range · as of 2026-09-28 $1.25 – $10.16
Market cap
$77.95M
Volume
1.4K (0.4× avg)
3-mo avg 3.1K
Live data · 2026-10-05 03:21 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed NORD - Latest Insights

NORD
Sep 28, 2026, 3:44 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $3.52
Real-time Price: $4.01 info
Change: +$0.489 (+14%) info
Market Cap: $77.951M info
NORD
Sep 16, 2026, 6:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.30
Real-time Price: $4.01 info
Change: +$0.709 (+21%) info
Market Cap: $77.951M info
NORD
Jul 14, 2026, 5:20 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $2.50
Real-time Price: $4.01 info
Change: +$1.51 (+60%) info
Market Cap: $77.951M info
NORD
Jun 23, 2026, 3:40 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.66
Real-time Price: $4.01 info
Change: +$2.35 (+141%) info
Market Cap: $77.951M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets